Cargando…
Guidance on Dravet syndrome from infant to adult care: Road map for treatment planning in Europe
Dravet syndrome (DS) is a severe, rare, and complex developmental and epileptic encephalopathy affecting 1 in 16 000 live births and characterized by a drug‐resistant epilepsy, cognitive, psychomotor, and language impairment, and behavioral disorders. Evidence suggests that optimal treatment of seiz...
Autores principales: | Cardenal‐Muñoz, Elena, Auvin, Stéphane, Villanueva, Vicente, Cross, J. Helen, Zuberi, Sameer M., Lagae, Lieven, Aibar, José Ángel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886070/ https://www.ncbi.nlm.nih.gov/pubmed/34882995 http://dx.doi.org/10.1002/epi4.12569 |
Ejemplares similares
-
Dravet syndrome: A systematic literature review of the illness burden
por: Strzelczyk, Adam, et al.
Publicado: (2023) -
Serotonergic modulation as a pharmacological modality in the treatment of Dravet syndrome
por: de Witte, Peter, et al.
Publicado: (2017) -
Impact of the COVID‐19 lockdown on patients and families with Dravet syndrome
por: Brambilla, Isabella, et al.
Publicado: (2021) -
Serotonin receptors in epilepsy: Novel treatment targets?
por: Sourbron, Jo, et al.
Publicado: (2022) -
Drug repurposing for Dravet syndrome in scn1Lab
(−/−) mutant zebrafish
por: Sourbron, Jo, et al.
Publicado: (2019)